Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CCTG 595: A Multicenter, Randomized Study of Text Messaging to Improve Adherence to PrEP in Risky MSM

NCT01761643 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT01761643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01761643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CCTG 595: A Multicenter, Randomized Study of Text Messaging to Improve Adherence to PrEP in Risky MSM
Lead sponsor
University of California, San Diego
Phase
Phase 4
Overall status
Completed
Start date
December 19, 2012
Completion date
July 11, 2018
Enrollment
398 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv seronegativity, patient adherence